Here are five things to know.
- The drugmaker’s revenue jumped to $7.39 billion, marking a 3.1 percent increase from quarter one of fiscal year 2017.
- Sales for Medtronic’s cardiac and vascular business increased 5.1 percent year over year to $2.65 billion. The unit accounted for almost 36 percent of the company’s total sales.
- Net income increased from $929 million in the first quarter of 2017 to $1.02 billion in the first quarter of 2018.
- Medtronic said the global computer outage it experienced in June had “some impact” on overall quarterly performance, but was not material to earnings or revenue, according to CNBC.
- The drugmaker maintained its full-year earnings and revenue forecasts, projecting adjusted earnings per share will increase 9 percent to 10 percent and revenue to rise 4 percent to 5 percent for the fiscal year ending in April 2018.
More articles on supply chain:
7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
CDC: Yellow fever vaccine out of stock
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
